Company registration number 05304904 (England and Wales)
CELENTYX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CELENTYX LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 9
CELENTYX LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
75,465
79,049
Current assets
Debtors
5
410,046
609,116
Cash at bank and in hand
727,511
574,746
1,137,557
1,183,862
Creditors: amounts falling due within one year
6
(90,563)
(262,659)
Net current assets
1,046,994
921,203
Total assets less current liabilities
1,122,459
1,000,252
Creditors: amounts falling due after more than one year
7
-
0
(3,749)
Provisions for liabilities
(14,338)
(19,762)
Net assets
1,108,121
976,741
Capital and reserves
Called up share capital
8
100
100
Share premium account
230,842
230,842
Capital redemption reserve
23
23
Other reserves
15,946
13,598
Profit and loss reserves
861,210
732,178
Total equity
1,108,121
976,741
CELENTYX LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 September 2026 and are signed on its behalf by:
Professor N M Barnes
Director
Company registration number 05304904 (England and Wales)
CELENTYX LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
Share capital
Share premium account
Capital redemption reserve
Other reserves
Profit and loss reserves
Total
£
£
£
£
£
£
Balance at 1 January 2024
100
230,842
23
11,250
525,851
768,066
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
-
-
206,327
206,327
Share based payments
-
-
-
2,348
-
0
2,348
Balance at 31 December 2024
100
230,842
23
13,598
732,178
976,741
Year ended 31 December 2025:
Profit and total comprehensive income
-
-
-
-
129,032
129,032
Share based payments
-
-
-
2,348
-
0
2,348
Balance at 31 December 2025
100
230,842
23
15,946
861,210
1,108,121
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
1
Accounting policies
Company information

Celentyx Limited is a private company limited by shares incorporated in England and Wales. The registered office is Birmingham Research Park, Edgbaston, Birmingham, B15 2SQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% reducing balance
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in bank only.

CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade debtors, other debtors, and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade creditors, corporation tax, other taxation and social security, and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Share-based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

1.12
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
13
13
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025
193,447
Additions
19,931
At 31 December 2025
213,378
Depreciation and impairment
At 1 January 2025
114,398
Depreciation charged in the year
23,515
At 31 December 2025
137,913
Carrying amount
At 31 December 2025
75,465
At 31 December 2024
79,049

Included within tangible fixed assets are assets held under finance leases or hire purchase contracts, as follows:

2025
2024
£
£
Plant and equipment
27,395
36,527
27,395
36,527
The depreciation charge in respect of such assets amounted to £9,132 (2024: £12,176)
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
142,305
535,460
Corporation tax recoverable
49,612
-
0
Other debtors
218,129
73,656
410,046
609,116
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
32,777
63,886
Corporation tax
-
0
64,001
Other taxation and social security
21,870
16,208
Other creditors
35,916
118,564
90,563
262,659

Included within other creditors falling due within one year are obligations under hire purchase of £3,749 (2024: £22,492), which are secured on the assets to which they relate.

7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
3,749

Included within other creditors falling due within one year are obligations under hire purchase of £Nil (2024: £3,749), which are secured on the assets to which they relate.

8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
9,790
9,790
98
98
U shares of £1 each
1
1
1
1
M shares of £1 each
1
1
1
1
9,792
9,792
100
100
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
65,914
13,636
10
Share-based payment transactions
Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
£
£
Outstanding at 1 January 2025 and 31 December 2025
1,096
1,096
35.91
35.91
Exercisable at 31 December 2025
-
0
-
0
-
0
-
0

The options outstanding at 31 December 2025 had an exercise price of £35.91, and a remaining contractual life of 4.21 years.

Inputs were as follows:
2025
2024
Weighted average share price
35.91
35.91
Weighted average exercise price
35.91
35.91
Expected volatility
50.00
50.00
Expected life
10.00
10.00
Risk free rate
1.21
1.21

During the year, the company recognised a charge of £2,348 (2024: £2,348) which related to equity settled share based payment transactions.

2025-12-312025-01-01falsefalsefalse15 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityProfessor A K BoydProfessor J GordonProfessor N M Barnes2026-09-15053049042025-01-012025-12-31053049042025-12-31053049042024-12-3105304904core:OtherPropertyPlantEquipment2025-12-3105304904core:OtherPropertyPlantEquipment2024-12-3105304904core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3105304904core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3105304904core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3105304904core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3105304904core:CurrentFinancialInstruments2025-12-3105304904core:CurrentFinancialInstruments2024-12-3105304904core:ShareCapital2025-12-3105304904core:ShareCapital2024-12-3105304904core:SharePremium2025-12-3105304904core:SharePremium2024-12-3105304904core:CapitalRedemptionReserve2025-12-3105304904core:CapitalRedemptionReserve2024-12-3105304904core:OtherMiscellaneousReserve2025-12-3105304904core:OtherMiscellaneousReserve2024-12-3105304904core:RetainedEarningsAccumulatedLosses2025-12-3105304904core:RetainedEarningsAccumulatedLosses2024-12-3105304904core:ShareCapital2023-12-3105304904core:SharePremium2023-12-3105304904core:CapitalRedemptionReserve2023-12-3105304904core:RetainedEarningsAccumulatedLosses2023-12-3105304904core:ShareCapitalOrdinaryShareClass12025-12-3105304904core:ShareCapitalOrdinaryShareClass12024-12-3105304904core:ShareCapitalOrdinaryShareClass32025-12-3105304904core:ShareCapitalOrdinaryShareClass32024-12-3105304904core:ShareCapitalOrdinaryShareClass42025-12-3105304904core:ShareCapitalOrdinaryShareClass42024-12-3105304904core:ShareCapitalOrdinaryShares2025-12-3105304904core:ShareCapitalOrdinaryShares2024-12-3105304904bus:Director32025-01-012025-12-3105304904core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31053049042024-01-012024-12-3105304904core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3105304904core:PlantMachinery2025-01-012025-12-3105304904core:OtherPropertyPlantEquipment2024-12-3105304904core:OtherPropertyPlantEquipment2025-01-012025-12-3105304904core:Non-currentFinancialInstruments2025-12-3105304904core:Non-currentFinancialInstruments2024-12-3105304904bus:OrdinaryShareClass12025-01-012025-12-3105304904bus:OrdinaryShareClass32025-01-012025-12-3105304904bus:OrdinaryShareClass42025-01-012025-12-3105304904bus:OrdinaryShareClass12025-12-3105304904bus:OrdinaryShareClass12024-12-3105304904bus:OrdinaryShareClass32025-12-3105304904bus:OrdinaryShareClass32024-12-3105304904bus:OrdinaryShareClass42025-12-3105304904bus:OrdinaryShareClass42024-12-3105304904bus:AllOrdinaryShares2025-12-3105304904bus:AllOrdinaryShares2024-12-31053049042024-12-31053049042023-12-3105304904bus:PrivateLimitedCompanyLtd2025-01-012025-12-3105304904bus:FRS1022025-01-012025-12-3105304904bus:AuditExemptWithAccountantsReport2025-01-012025-12-3105304904bus:Director12025-01-012025-12-3105304904bus:Director22025-01-012025-12-3105304904bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3105304904bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP